Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 16 AL 30

Selecting a mouse model of Alzheimer's disease

Chin J.

Methods Mol Biol. 2011;670:169-89. doi: 10.1007/978-1-60761-744-0_13.

Glaucoma progression associated with altered cerebral spinal fluid levels of amyloid beta and tau proteins

Nucci C, Martucci A, Martorana A, Sancesario GM, Cerulli L.

Clin Exp Ophthalmol. 2011 Apr;39(3):279-81. doi: 10.1111/j.1442-9071.2010.02452.x.

Effects of body weight on tolerability of rivastigmine transdermal patch: a post-hoc analysis of a double-blind trial in patients with Alzheimer disease

Lee JH, Sevigny J.

Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):58-62. doi: 10.1097/WAD.0b013e3181f32829.

The case for blood-brain barrier dysfunction in the pathogenesis of Alzheimer's disease

Jeynes B, Provias J.

J Neurosci Res. 2011 Jan;89(1):22-8. doi: 10.1002/jnr.22527.

A systematic review to assess the policy-making relevance of dementia cost-of-illness studies in the US and Canada

Oremus M, Aguilar SC.

Pharmacoeconomics. 2011 Feb;29(2):141-56. doi: 10.2165/11539450-000000000-00000.

The reduction of baseline serotonin 2A receptors in mild cognitive impairment is stable at two-year follow-up

Marner L, Knudsen GM, Madsen K, Holm S, Baaré W, Hasselbalch SG.

J Alzheimers Dis. 2011;23(3):453-9. doi: 10.3233/JAD-2010-100903.

Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade?

Aznar S, Knudsen GM.

J Alzheimers Dis. 2011;23(2):177-93. doi: 10.3233/JAD-2010-100390.

Morphological cerebral correlates of CERAD test performance in mild cognitive impairment and Alzheimer's disease

Dos Santos V, Thomann PA, Wüstenberg T, Seidl U, Essig M, Schröder J.

J Alzheimers Dis. 2011;23(3):411-20. doi: 10.3233/JAD-2010-100156.

Recent developments in tau-based therapeutics for neurodegenerative diseases

Medina M.

Recent Pat CNS Drug Discov. 2011 Jan;6(1):20-30. doi: 10.2174/157488911794079091.

Towards integrative gene prioritization in Alzheimer's disease

Lee JH, Gonzalez GH.

Pac Symp Biocomput. 2011:4-13. doi: 10.1142/9789814335058_0002.

Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology

Hoozemans JJ, Veerhuis R, Rozemuller JM, Eikelenboom P.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):57-67. doi: 10.2174/187152711794488665.

Kallikrein-kinin system mediated inflammation in Alzheimer's disease in vivo

Viel TA, Buck HS.

Curr Alzheimer Res. 2011 Feb;8(1):59-66. doi: 10.2174/156720511794604570.

Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease

Li C, Zhao R, Gao K, Wei Z, Yin MY, Lau LT, Chui D, Yu AC.

Curr Alzheimer Res. 2011 Feb;8(1):67-80. doi: 10.2174/156720511794604543.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias